Critical appraisal study day

We are pleased to be able to host our inaugural critical appraisal study day.  The day will be in collaboration with the UCLs Centre for Medicines Optimisation and Research and will be free to BOPA members only.
 
The session will be for 15-20 candidates on July 1st 10-3 and will enable you to develop the skills you need to contribute effectively and possibly run your own journal clubs.  We would like the small group to continue to collaborate and can facilitate this in future through dissemination of interesting papers that can be read to keep up the valuable skills you will learn.
 
What you will learn
 
·         an introduction to critical appraisal
·         characteristics of different types of  study designs.
·         an understanding of measures of effect for quantitative data( risk rations, odds ratios)
·         Understanding meta- analysis and forest plots.
·         Understanding of bias
·         The use of critical appraisal checklists.  
Please contact me if you are interested in attending by May 20th ( [email protected]
 
Best Wishes
 
Pinkie 
On behalf of A&R and E&T committees
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article